Bioventus Inc. Debt-to-equity in % from Q4 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bioventus Inc. quarterly Debt-to-equity history and growth rate from Q4 2021 to Q3 2025.
  • Bioventus Inc. Debt-to-equity for the quarter ending September 27, 2025 was 329 %, a 9.98% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

Bioventus Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 329 -36.4 -9.98% Sep 27, 2025
Q2 2025 353 +2.85 +0.82% Jun 28, 2025
Q1 2025 375 +41.3 +12.4% Mar 29, 2025
Q4 2024 372 +36.9 +11% Dec 31, 2024
Q3 2024 365 +45.3 +14.2% Sep 28, 2024
Q2 2024 350 +39.2 +12.6% Jun 29, 2024
Q1 2024 334 +79.8 +31.4% Mar 30, 2024
Q4 2023 336 +122 +57.2% Dec 31, 2023
Q3 2023 320 +143 +81.1% Sep 30, 2023
Q2 2023 310 +151 +94.7% Jul 1, 2023
Q1 2023 254 +75.7 +42.4% Apr 1, 2023
Q4 2022 213 +2.06 +0.98% Dec 31, 2022
Q3 2022 177 Oct 1, 2022
Q2 2022 159 Jul 2, 2022
Q1 2022 178 Apr 2, 2022
Q4 2021 211 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.